Global Molecular Diagnostics Infectious Disease Testing Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.
LPI (LP Information)' newest research report, the “Molecular Diagnostics Infectious Disease Testing Industry Forecast” looks at past sales and reviews total world Molecular Diagnostics Infectious Disease Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics Infectious Disease Testing sales for 2023 through 2029. With Molecular Diagnostics Infectious Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics Infectious Disease Testing industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics Infectious Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Diagnostics Infectious Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Diagnostics Infectious Disease Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics Infectious Disease Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics Infectious Disease Testing.
The global Molecular Diagnostics Infectious Disease Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Molecular Diagnostics Infectious Disease Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Molecular Diagnostics Infectious Disease Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Molecular Diagnostics Infectious Disease Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Molecular Diagnostics Infectious Disease Testing players cover Abbott Laboratories, BD, bioM?rieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens AG, Veridex, Luminex and GenMark Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Infectious Disease Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.
LPI (LP Information)' newest research report, the “Molecular Diagnostics Infectious Disease Testing Industry Forecast” looks at past sales and reviews total world Molecular Diagnostics Infectious Disease Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostics Infectious Disease Testing sales for 2023 through 2029. With Molecular Diagnostics Infectious Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostics Infectious Disease Testing industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostics Infectious Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Diagnostics Infectious Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Diagnostics Infectious Disease Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostics Infectious Disease Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostics Infectious Disease Testing.
The global Molecular Diagnostics Infectious Disease Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Molecular Diagnostics Infectious Disease Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Molecular Diagnostics Infectious Disease Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Molecular Diagnostics Infectious Disease Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Molecular Diagnostics Infectious Disease Testing players cover Abbott Laboratories, BD, bioM?rieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens AG, Veridex, Luminex and GenMark Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Infectious Disease Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Bacterial Infectious Disease Testing
- Viral Infectious Disease Testing
- Parasitic Infectious Disease Testing
- Hospital
- Laboratory Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- BD
- bioM?rieux
- Thermo Fisher Scientific
- F. Hoffmann-La Roche
- Siemens AG
- Veridex
- Luminex
- GenMark Diagnostics
- Qiagen NV
- Genomix Biotech
- BioTheranostics
- GenMark Diagnostics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Infectious Disease Testing Market Size 2018-2029
2.1.2 Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Molecular Diagnostics Infectious Disease Testing Segment by Type
2.2.1 Bacterial Infectious Disease Testing
2.2.2 Viral Infectious Disease Testing
2.2.3 Parasitic Infectious Disease Testing
2.3 Molecular Diagnostics Infectious Disease Testing Market Size by Type
2.3.1 Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
2.4 Molecular Diagnostics Infectious Disease Testing Segment by Application
2.4.1 Hospital
2.4.2 Laboratory Research
2.5 Molecular Diagnostics Infectious Disease Testing Market Size by Application
2.5.1 Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
3 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET SIZE BY PLAYER
3.1 Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Players
3.1.1 Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2018-2023)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnostics Infectious Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING BY REGIONS
4.1 Molecular Diagnostics Infectious Disease Testing Market Size by Regions (2018-2023)
4.2 Americas Molecular Diagnostics Infectious Disease Testing Market Size Growth (2018-2023)
4.3 APAC Molecular Diagnostics Infectious Disease Testing Market Size Growth (2018-2023)
4.4 Europe Molecular Diagnostics Infectious Disease Testing Market Size Growth (2018-2023)
4.5 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Molecular Diagnostics Infectious Disease Testing Market Size by Country (2018-2023)
5.2 Americas Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023)
5.3 Americas Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Infectious Disease Testing Market Size by Region (2018-2023)
6.2 APAC Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023)
6.3 APAC Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Diagnostics Infectious Disease Testing by Country (2018-2023)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023)
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing by Region (2018-2023)
8.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023)
8.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET FORECAST
10.1 Global Molecular Diagnostics Infectious Disease Testing Forecast by Regions (2024-2029)
10.1.1 Global Molecular Diagnostics Infectious Disease Testing Forecast by Regions (2024-2029)
10.1.2 Americas Molecular Diagnostics Infectious Disease Testing Forecast
10.1.3 APAC Molecular Diagnostics Infectious Disease Testing Forecast
10.1.4 Europe Molecular Diagnostics Infectious Disease Testing Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Forecast
10.2 Americas Molecular Diagnostics Infectious Disease Testing Forecast by Country (2024-2029)
10.2.1 United States Molecular Diagnostics Infectious Disease Testing Market Forecast
10.2.2 Canada Molecular Diagnostics Infectious Disease Testing Market Forecast
10.2.3 Mexico Molecular Diagnostics Infectious Disease Testing Market Forecast
10.2.4 Brazil Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3 APAC Molecular Diagnostics Infectious Disease Testing Forecast by Region (2024-2029)
10.3.1 China Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.2 Japan Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.3 Korea Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.4 Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.5 India Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.6 Australia Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4 Europe Molecular Diagnostics Infectious Disease Testing Forecast by Country (2024-2029)
10.4.1 Germany Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.2 France Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.3 UK Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.4 Italy Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.5 Russia Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Forecast by Region (2024-2029)
10.5.1 Egypt Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.2 South Africa Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.3 Israel Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.4 Turkey Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.5 GCC Countries Molecular Diagnostics Infectious Disease Testing Market Forecast
10.6 Global Molecular Diagnostics Infectious Disease Testing Forecast by Type (2024-2029)
10.7 Global Molecular Diagnostics Infectious Disease Testing Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Offered
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD Molecular Diagnostics Infectious Disease Testing Product Offered
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 bioM?rieux
11.3.1 bioM?rieux Company Information
11.3.2 bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Offered
11.3.3 bioM?rieux Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 bioM?rieux Main Business Overview
11.3.5 bioM?rieux Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Offered
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Information
11.5.2 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Offered
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 F. Hoffmann-La Roche Main Business Overview
11.5.5 F. Hoffmann-La Roche Latest Developments
11.6 Siemens AG
11.6.1 Siemens AG Company Information
11.6.2 Siemens AG Molecular Diagnostics Infectious Disease Testing Product Offered
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Siemens AG Main Business Overview
11.6.5 Siemens AG Latest Developments
11.7 Veridex
11.7.1 Veridex Company Information
11.7.2 Veridex Molecular Diagnostics Infectious Disease Testing Product Offered
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Veridex Main Business Overview
11.7.5 Veridex Latest Developments
11.8 Luminex
11.8.1 Luminex Company Information
11.8.2 Luminex Molecular Diagnostics Infectious Disease Testing Product Offered
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Luminex Main Business Overview
11.8.5 Luminex Latest Developments
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Information
11.9.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 GenMark Diagnostics Main Business Overview
11.9.5 GenMark Diagnostics Latest Developments
11.10 Qiagen NV
11.10.1 Qiagen NV Company Information
11.10.2 Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Offered
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Qiagen NV Main Business Overview
11.10.5 Qiagen NV Latest Developments
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Information
11.11.2 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Offered
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Genomix Biotech Main Business Overview
11.11.5 Genomix Biotech Latest Developments
11.12 BioTheranostics
11.12.1 BioTheranostics Company Information
11.12.2 BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Offered
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 BioTheranostics Main Business Overview
11.12.5 BioTheranostics Latest Developments
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Information
11.13.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 GenMark Diagnostics Main Business Overview
11.13.5 GenMark Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Infectious Disease Testing Market Size 2018-2029
2.1.2 Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Molecular Diagnostics Infectious Disease Testing Segment by Type
2.2.1 Bacterial Infectious Disease Testing
2.2.2 Viral Infectious Disease Testing
2.2.3 Parasitic Infectious Disease Testing
2.3 Molecular Diagnostics Infectious Disease Testing Market Size by Type
2.3.1 Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
2.4 Molecular Diagnostics Infectious Disease Testing Segment by Application
2.4.1 Hospital
2.4.2 Laboratory Research
2.5 Molecular Diagnostics Infectious Disease Testing Market Size by Application
2.5.1 Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
3 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET SIZE BY PLAYER
3.1 Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Players
3.1.1 Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2018-2023)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnostics Infectious Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING BY REGIONS
4.1 Molecular Diagnostics Infectious Disease Testing Market Size by Regions (2018-2023)
4.2 Americas Molecular Diagnostics Infectious Disease Testing Market Size Growth (2018-2023)
4.3 APAC Molecular Diagnostics Infectious Disease Testing Market Size Growth (2018-2023)
4.4 Europe Molecular Diagnostics Infectious Disease Testing Market Size Growth (2018-2023)
4.5 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Molecular Diagnostics Infectious Disease Testing Market Size by Country (2018-2023)
5.2 Americas Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023)
5.3 Americas Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Infectious Disease Testing Market Size by Region (2018-2023)
6.2 APAC Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023)
6.3 APAC Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Diagnostics Infectious Disease Testing by Country (2018-2023)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023)
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing by Region (2018-2023)
8.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023)
8.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET FORECAST
10.1 Global Molecular Diagnostics Infectious Disease Testing Forecast by Regions (2024-2029)
10.1.1 Global Molecular Diagnostics Infectious Disease Testing Forecast by Regions (2024-2029)
10.1.2 Americas Molecular Diagnostics Infectious Disease Testing Forecast
10.1.3 APAC Molecular Diagnostics Infectious Disease Testing Forecast
10.1.4 Europe Molecular Diagnostics Infectious Disease Testing Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Forecast
10.2 Americas Molecular Diagnostics Infectious Disease Testing Forecast by Country (2024-2029)
10.2.1 United States Molecular Diagnostics Infectious Disease Testing Market Forecast
10.2.2 Canada Molecular Diagnostics Infectious Disease Testing Market Forecast
10.2.3 Mexico Molecular Diagnostics Infectious Disease Testing Market Forecast
10.2.4 Brazil Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3 APAC Molecular Diagnostics Infectious Disease Testing Forecast by Region (2024-2029)
10.3.1 China Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.2 Japan Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.3 Korea Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.4 Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.5 India Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.6 Australia Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4 Europe Molecular Diagnostics Infectious Disease Testing Forecast by Country (2024-2029)
10.4.1 Germany Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.2 France Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.3 UK Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.4 Italy Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.5 Russia Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Forecast by Region (2024-2029)
10.5.1 Egypt Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.2 South Africa Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.3 Israel Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.4 Turkey Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.5 GCC Countries Molecular Diagnostics Infectious Disease Testing Market Forecast
10.6 Global Molecular Diagnostics Infectious Disease Testing Forecast by Type (2024-2029)
10.7 Global Molecular Diagnostics Infectious Disease Testing Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Offered
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD Molecular Diagnostics Infectious Disease Testing Product Offered
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 bioM?rieux
11.3.1 bioM?rieux Company Information
11.3.2 bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Offered
11.3.3 bioM?rieux Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 bioM?rieux Main Business Overview
11.3.5 bioM?rieux Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Offered
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Information
11.5.2 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Offered
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 F. Hoffmann-La Roche Main Business Overview
11.5.5 F. Hoffmann-La Roche Latest Developments
11.6 Siemens AG
11.6.1 Siemens AG Company Information
11.6.2 Siemens AG Molecular Diagnostics Infectious Disease Testing Product Offered
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Siemens AG Main Business Overview
11.6.5 Siemens AG Latest Developments
11.7 Veridex
11.7.1 Veridex Company Information
11.7.2 Veridex Molecular Diagnostics Infectious Disease Testing Product Offered
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Veridex Main Business Overview
11.7.5 Veridex Latest Developments
11.8 Luminex
11.8.1 Luminex Company Information
11.8.2 Luminex Molecular Diagnostics Infectious Disease Testing Product Offered
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Luminex Main Business Overview
11.8.5 Luminex Latest Developments
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Information
11.9.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 GenMark Diagnostics Main Business Overview
11.9.5 GenMark Diagnostics Latest Developments
11.10 Qiagen NV
11.10.1 Qiagen NV Company Information
11.10.2 Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Offered
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Qiagen NV Main Business Overview
11.10.5 Qiagen NV Latest Developments
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Information
11.11.2 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Offered
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Genomix Biotech Main Business Overview
11.11.5 Genomix Biotech Latest Developments
11.12 BioTheranostics
11.12.1 BioTheranostics Company Information
11.12.2 BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Offered
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 BioTheranostics Main Business Overview
11.12.5 BioTheranostics Latest Developments
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Information
11.13.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 GenMark Diagnostics Main Business Overview
11.13.5 GenMark Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Bacterial Infectious Disease Testing
Table 3. Major Players of Viral Infectious Disease Testing
Table 4. Major Players of Parasitic Infectious Disease Testing
Table 5. Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 8. Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 11. Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Player (2018-2023)
Table 13. Molecular Diagnostics Infectious Disease Testing Key Players Head office and Products Offered
Table 14. Molecular Diagnostics Infectious Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Molecular Diagnostics Infectious Disease Testing Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Regions (2018-2023)
Table 19. Global Molecular Diagnostics Infectious Disease Testing Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Molecular Diagnostics Infectious Disease Testing Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Country (2018-2023)
Table 23. Americas Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 25. Americas Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 27. APAC Molecular Diagnostics Infectious Disease Testing Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region (2018-2023)
Table 29. APAC Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 31. APAC Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 33. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Country (2018-2023)
Table 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 37. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Molecular Diagnostics Infectious Disease Testing
Table 46. Key Market Challenges & Risks of Molecular Diagnostics Infectious Disease Testing
Table 47. Key Industry Trends of Molecular Diagnostics Infectious Disease Testing
Table 48. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Abbott Laboratories Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 53. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Offered
Table 54. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Abbott Laboratories Main Business
Table 56. Abbott Laboratories Latest Developments
Table 57. BD Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 58. BD Molecular Diagnostics Infectious Disease Testing Product Offered
Table 59. BD Main Business
Table 60. BD Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. BD Latest Developments
Table 62. bioM?rieux Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 63. bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Offered
Table 64. bioM?rieux Main Business
Table 65. bioM?rieux Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. bioM?rieux Latest Developments
Table 67. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 68. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Offered
Table 69. Thermo Fisher Scientific Main Business
Table 70. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Thermo Fisher Scientific Latest Developments
Table 72. F. Hoffmann-La Roche Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 73. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Offered
Table 74. F. Hoffmann-La Roche Main Business
Table 75. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. F. Hoffmann-La Roche Latest Developments
Table 77. Siemens AG Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 78. Siemens AG Molecular Diagnostics Infectious Disease Testing Product Offered
Table 79. Siemens AG Main Business
Table 80. Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Siemens AG Latest Developments
Table 82. Veridex Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 83. Veridex Molecular Diagnostics Infectious Disease Testing Product Offered
Table 84. Veridex Main Business
Table 85. Veridex Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Veridex Latest Developments
Table 87. Luminex Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 88. Luminex Molecular Diagnostics Infectious Disease Testing Product Offered
Table 89. Luminex Main Business
Table 90. Luminex Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Luminex Latest Developments
Table 92. GenMark Diagnostics Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 93. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
Table 94. GenMark Diagnostics Main Business
Table 95. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. GenMark Diagnostics Latest Developments
Table 97. Qiagen NV Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 98. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Offered
Table 99. Qiagen NV Main Business
Table 100. Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Qiagen NV Latest Developments
Table 102. Genomix Biotech Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 103. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Offered
Table 104. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Genomix Biotech Main Business
Table 106. Genomix Biotech Latest Developments
Table 107. BioTheranostics Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 108. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Offered
Table 109. BioTheranostics Main Business
Table 110. BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. BioTheranostics Latest Developments
Table 112. GenMark Diagnostics Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 113. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
Table 114. GenMark Diagnostics Main Business
Table 115. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. GenMark Diagnostics Latest Developments
Table 1. Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Bacterial Infectious Disease Testing
Table 3. Major Players of Viral Infectious Disease Testing
Table 4. Major Players of Parasitic Infectious Disease Testing
Table 5. Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 8. Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 11. Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Player (2018-2023)
Table 13. Molecular Diagnostics Infectious Disease Testing Key Players Head office and Products Offered
Table 14. Molecular Diagnostics Infectious Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Molecular Diagnostics Infectious Disease Testing Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Regions (2018-2023)
Table 19. Global Molecular Diagnostics Infectious Disease Testing Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Molecular Diagnostics Infectious Disease Testing Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Country (2018-2023)
Table 23. Americas Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 25. Americas Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 27. APAC Molecular Diagnostics Infectious Disease Testing Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region (2018-2023)
Table 29. APAC Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 31. APAC Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 33. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Country (2018-2023)
Table 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 37. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Molecular Diagnostics Infectious Disease Testing
Table 46. Key Market Challenges & Risks of Molecular Diagnostics Infectious Disease Testing
Table 47. Key Industry Trends of Molecular Diagnostics Infectious Disease Testing
Table 48. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Abbott Laboratories Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 53. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Offered
Table 54. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Abbott Laboratories Main Business
Table 56. Abbott Laboratories Latest Developments
Table 57. BD Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 58. BD Molecular Diagnostics Infectious Disease Testing Product Offered
Table 59. BD Main Business
Table 60. BD Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. BD Latest Developments
Table 62. bioM?rieux Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 63. bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Offered
Table 64. bioM?rieux Main Business
Table 65. bioM?rieux Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. bioM?rieux Latest Developments
Table 67. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 68. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Offered
Table 69. Thermo Fisher Scientific Main Business
Table 70. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Thermo Fisher Scientific Latest Developments
Table 72. F. Hoffmann-La Roche Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 73. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Offered
Table 74. F. Hoffmann-La Roche Main Business
Table 75. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. F. Hoffmann-La Roche Latest Developments
Table 77. Siemens AG Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 78. Siemens AG Molecular Diagnostics Infectious Disease Testing Product Offered
Table 79. Siemens AG Main Business
Table 80. Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Siemens AG Latest Developments
Table 82. Veridex Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 83. Veridex Molecular Diagnostics Infectious Disease Testing Product Offered
Table 84. Veridex Main Business
Table 85. Veridex Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Veridex Latest Developments
Table 87. Luminex Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 88. Luminex Molecular Diagnostics Infectious Disease Testing Product Offered
Table 89. Luminex Main Business
Table 90. Luminex Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Luminex Latest Developments
Table 92. GenMark Diagnostics Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 93. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
Table 94. GenMark Diagnostics Main Business
Table 95. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. GenMark Diagnostics Latest Developments
Table 97. Qiagen NV Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 98. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Offered
Table 99. Qiagen NV Main Business
Table 100. Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Qiagen NV Latest Developments
Table 102. Genomix Biotech Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 103. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Offered
Table 104. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Genomix Biotech Main Business
Table 106. Genomix Biotech Latest Developments
Table 107. BioTheranostics Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 108. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Offered
Table 109. BioTheranostics Main Business
Table 110. BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. BioTheranostics Latest Developments
Table 112. GenMark Diagnostics Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 113. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
Table 114. GenMark Diagnostics Main Business
Table 115. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. GenMark Diagnostics Latest Developments
LIST OF FIGURES
Figure 1. Molecular Diagnostics Infectious Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Molecular Diagnostics Infectious Disease Testing Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country/Region (2022)
Figure 8. Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type in 2022
Figure 10. Molecular Diagnostics Infectious Disease Testing in Hospital
Figure 11. Global Molecular Diagnostics Infectious Disease Testing Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Molecular Diagnostics Infectious Disease Testing in Laboratory Research
Figure 13. Global Molecular Diagnostics Infectious Disease Testing Market: Laboratory Research (2018-2023) & ($ Millions)
Figure 14. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application in 2022
Figure 15. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Player in 2022
Figure 16. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Molecular Diagnostics Infectious Disease Testing Market Size 2018-2023 ($ Millions)
Figure 18. APAC Molecular Diagnostics Infectious Disease Testing Market Size 2018-2023 ($ Millions)
Figure 19. Europe Molecular Diagnostics Infectious Disease Testing Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size 2018-2023 ($ Millions)
Figure 21. Americas Molecular Diagnostics Infectious Disease Testing Value Market Share by Country in 2022
Figure 22. United States Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region in 2022
Figure 27. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type in 2022
Figure 28. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application in 2022
Figure 29. China Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Country in 2022
Figure 36. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Figure 37. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Figure 38. Germany Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 52. APAC Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 53. Europe Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 55. United States Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 56. Canada Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 59. China Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 60. Japan Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 61. Korea Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 63. India Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 64. Australia Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 65. Germany Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 66. France Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 67. UK Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 68. Italy Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 69. Russia Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 70. Spain Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 73. Israel Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 76. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Molecular Diagnostics Infectious Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Molecular Diagnostics Infectious Disease Testing Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country/Region (2022)
Figure 8. Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type in 2022
Figure 10. Molecular Diagnostics Infectious Disease Testing in Hospital
Figure 11. Global Molecular Diagnostics Infectious Disease Testing Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Molecular Diagnostics Infectious Disease Testing in Laboratory Research
Figure 13. Global Molecular Diagnostics Infectious Disease Testing Market: Laboratory Research (2018-2023) & ($ Millions)
Figure 14. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application in 2022
Figure 15. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Player in 2022
Figure 16. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Molecular Diagnostics Infectious Disease Testing Market Size 2018-2023 ($ Millions)
Figure 18. APAC Molecular Diagnostics Infectious Disease Testing Market Size 2018-2023 ($ Millions)
Figure 19. Europe Molecular Diagnostics Infectious Disease Testing Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size 2018-2023 ($ Millions)
Figure 21. Americas Molecular Diagnostics Infectious Disease Testing Value Market Share by Country in 2022
Figure 22. United States Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region in 2022
Figure 27. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type in 2022
Figure 28. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application in 2022
Figure 29. China Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Country in 2022
Figure 36. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Figure 37. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Figure 38. Germany Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Molecular Diagnostics Infectious Disease Testing Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 52. APAC Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 53. Europe Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 55. United States Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 56. Canada Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 59. China Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 60. Japan Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 61. Korea Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 63. India Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 64. Australia Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 65. Germany Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 66. France Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 67. UK Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 68. Italy Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 69. Russia Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 70. Spain Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 73. Israel Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Molecular Diagnostics Infectious Disease Testing Market Size 2024-2029 ($ Millions)
Figure 76. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share Forecast by Application (2024-2029)
